CLL study tracks 2000 patients to uncover survival secrets
NCT ID NCT06792994
First seen Jan 08, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study follows 2000 people with chronic lymphocytic leukemia (CLL) who received their first treatment in earlier clinical trials. Researchers want to see how long patients live and what factors affect their survival over time. No new treatments are given; this is an observational study to learn from real-world outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Cologne
RECRUITINGCologne, 50924, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Ulm
RECRUITINGUlm, 89081, Germany
Conditions
Explore the condition pages connected to this study.